Medical News

RSS

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight gain, which is common after surgery and can lead to serious complications for transplant patients.

3 May 2017

Scientists discover new cause of dangerous cardiac instabilities

Sudden cardiac death resulting from fibrillation – erratic heartbeat due to electrical instability – is one of the leading causes of death in the United States.

3 May 2017

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

A newly released study published in the Journal of Immunity, Inflammation and Disease and conducted by the Sapienza University of Rome, Italy, found a multi-strain, high concentration, probiotic formulation that helped reconstitute the physical and immunological integrity of the gastrointestinal lining in HIV-1-positive patients on antiretroviral therapy.

3 May 2017

Prenatal cocaine exposure linked to increased risk of drug use among teens

While the crack cocaine epidemic peaked in the late 1980's, its effects are still causing harm to an estimated 3 million teenagers and young adults exposed to the stimulant in the womb.

3 May 2017

Scientists develop new processing method to extract valuable biomolecules from wheat bran

It's usually used as livestock feed, but wheat bran's value in human nutrition and medicine may soon reach its full potential with a new sustainable processing method developed by Swedish researchers.

3 May 2017

TSRI study reveals clues to where tumor metastases are born

Scientists at The Scripps Research Institute have discovered why some cancers may reoccur after years in remission.

3 May 2017

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.

3 May 2017

Adventist Health System, Bio-Optronics partner on CTMS deployment to foster clinical research excellence

Bio-Optronics and Adventist Health System (AHS) have announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system’s research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization’s overall research quality.

3 May 2017

Standardized cigarette packaging may reduce number of people who smoke

According to the World Health Organization, tobacco use kills more people worldwide than any other preventable cause of death. Global health experts believe the best way to reduce tobacco use is by stopping people starting to use tobacco, and encouraging and helping existing users to stop.

3 May 2017

Limbcare launches new amputees user group at Frimley Park Hospital

National charity Limbcare, which supports amputees across the UK, is delighted to announce the launch of a new User Group to support amputees, their families, friends and carers at Frimley Park Hospital.

3 May 2017

Study shows first evidence of cognitive flexibility in bilinguals

Language has such a powerful effect, it can influence the way in which we experience time, according to a new study.

3 May 2017

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis’ PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.

3 May 2017

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, “The State of Biosimilars Policy.” The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.

3 May 2017

Researchers uncover new mechanism that explains cause of portal hypertension

Investigators at the Medical University of South Carolina have identified a critical regulatory mechanism for the production of nitric oxide. Endothelial nitric oxide synthase is the enzyme responsible for the production of NO and its activity is tightly controlled in liver endothelial cells via a series of complex molecular mechanisms; however, in liver injury, eNOS activity, and subsequently NO production, is dysregulated.

3 May 2017

New research on nanodiamond-enhanced MRI

Research by a collaboration of scientists in Australia and the United States demonstrates that using nanodiamonds somewhat like ‘tiny machines’ inside living patients has taken a quantum leap closer to reality.

3 May 2017

New acoustic system from ruling out CAD presented at Swedish Society of Cardiology Meeting

In preparation for launch in the Swedish and Danish markets, Swedish/Danish Acarix AB’s (publ) (“Acarix”) CADScor®System will be on display at the Swedish Society of Cardiology spring meeting in Malmö, April 26-28. Delegates will have the opportunity to review first results from a study that was presented at the American College of Cardiology Annual Scientific Meeting held in Washington, March 17-19, 2017 showing that CADScor®System rules out CAD with 97% negative predictive value.

3 May 2017

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics® and personalized molecular medicine®, today announces the premarket approval of LeukoStrat® CDx FLT3 Mutation Assay.

3 May 2017

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.

3 May 2017

Microthreaded dental implants preserve crestal bone

Journal of Oral Implantology – Tooth loss is not simply an aesthetic problem for adults. It can have severe consequences to overall dental health, including complications with speech, eating, and overcompensation of mouth due to the deficiency.

3 May 2017

Discovery of protein that causes liver disease brings hope for new treatments

In a world-first discovery, scientists at Sydney’s Westmead Institute for Medical Research have identified a protein that causes liver fibrosis (scarring), paving the way for new treatments for liver disease to be developed.

3 May 2017

Medical News

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Scientists discover new cause of dangerous cardiac instabilities

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

Prenatal cocaine exposure linked to increased risk of drug use among teens

Scientists develop new processing method to extract valuable biomolecules from wheat bran

TSRI study reveals clues to where tumor metastases are born

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Adventist Health System, Bio-Optronics partner on CTMS deployment to foster clinical research excellence

Standardized cigarette packaging may reduce number of people who smoke

Limbcare launches new amputees user group at Frimley Park Hospital

Study shows first evidence of cognitive flexibility in bilinguals

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

Researchers uncover new mechanism that explains cause of portal hypertension

New research on nanodiamond-enhanced MRI

New acoustic system from ruling out CAD presented at Swedish Society of Cardiology Meeting

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Microthreaded dental implants preserve crestal bone

Discovery of protein that causes liver disease brings hope for new treatments

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News